期刊文献+

库欣综合征的心血管疾病危险因素 被引量:3

The cardiovascular risk factors in Cushing's syndrome
原文传递
导出
摘要 库欣综合征患者往往伴有一系列全身性代谢合并症如中心性肥胖、高血压、胰岛素抵抗、糖代谢异常、血脂紊乱、血液高凝状态等。这些表现均为代谢综合征的特征,也是重要的心血管疾病危险因素。库欣综合征与代谢综合征联系密切,可以作为研究代谢综合征的模型。库欣综合征患者治愈、皮质醇水平恢复正常后仍有可能存在与疾病活动期类似的代谢紊乱和心血管疾病危险因素。 Cushing's syndrome is characterized by a series of systemic complications, including abdominal obesity, hypertension, insulin resistance, impairment of glucose metabolism, dyslipidemia, hypercoagulabale state, etc. These characteristics are features of metabolic syndrome, which also are important cardiovascular risk factors. As a useful model for the research of metabolic syndrome, Cushing's syndrome has a close relationship with it. The remission or normalization of circulating cortisol levels of patients with Cushing's syndrome is not always followed by completely disappearance of metabolic disorder and cardiovascular risk factors which existed in the active phase of the disease.
出处 《国际内分泌代谢杂志》 2007年第5期345-347,共3页 International Journal of Endocrinology and Metabolism
关键词 库欣综合征 心血管疾病 危险因素 代谢综合征 Cushing's syndrome Cardiovascular disease Risk factors Metabolic syndrome
  • 相关文献

参考文献15

  • 1Andrew R, Gale CR, Walker BR, et al. Glucocorticoid metabolisnl and the metabolic syndrome: associations in an elderly cohort. Exp Clin Endocrinol Diabetes,2002,110:284-290.
  • 2Faggiano A,Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliher and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endoerinol Metab ,2003,88:2527-2533.
  • 3Gabriely I Ma XH,Yang XM,et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes,2002,51:2951-2958.
  • 4Lindsay RS, Wake D J, Nair S, et al. Subcutaneous adipose 11 beta- hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab, 2003,88: 2738-2744.
  • 5Tomlinson JM, Draper N, Maekie J,et al. Absence of cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to eortisol conversion. J Clin Endoerinol Metab,2002,87:57-62.
  • 6Hermanowski-Vosatka A, Balkovec JM, Cheng K, et al. 11β-HSD1 inhibition ameliorates metabolie syndrome and prevents progression of atheroselerosis in mice. J Exp Med ,2005,202:517-527.
  • 7Alberts P,Nilsson C, Selen G. Selective inhibition of 11 beta-hydroxvsteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology ,2003,144:4755-4762.
  • 8Souverein PC, Berard A, Van Staa TP, et al. Use of oral glucocovticolds and risk of cardiovascular and eerebrovaseular disease in a population based case-control study. Heart,2004,90:859-865.
  • 9Wei L, MacDonald TM, Walker BR. Taking glucoeorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med,2004,141:764-770.
  • 10Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis,2003,62:1071-1077.

同被引文献15

  • 1Lynnette K,Nieman M,Beverly M,et al.The diagnosis of Cushing's syndrome:an endoscrine society clinical practice guideline [J].J olin Endocrim Metab,2008,1210:2008-2125.
  • 2Doi M,Sekizawa N,Tani Y,et al.Late night salivary cortisoi as a screening test for the diagnosis of Cushing's syndrome in Japan [J].Endocr J, 2008,55(1):121-126.
  • 3Elamin MB,Murad MH, Mullan R,et al.Accuracy of diagnostic tests fbr Cushing's syndrome:a systematic review and metaanalyses [J].Joural of clinical Endocrinology & Metabolism,2008,93(5): 1553-1562.
  • 4Gaioglu N,Ulu MO,Ozlen F,et al.Management of Cushing's disease using cavernous sinus sampling:effectiven in tumor lateralization[J].Clin Neurol Neurosurg,2008,110(4):333-338.
  • 5Tsagarakis S,Vassiliadi D,Kaskarelis IS,ct al.The application of the combined corticotropin -releasing hormone plus desmoprcssin stimulation during petrosal sinus sampling is hoth sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome[J].J Clin Endocrinol Metab, 2007,92(6):2080-2086.
  • 6Gandhi CD,Meyer SA,Patel AB,et at.Ncurulogic complications of inferior petrosal sinus sampling[J1.AJNR,2008,29(4):760--765.
  • 7陈灏珠.实用内科学[M]11版[M].北京:人民卫生出版社,2001.957-959.
  • 8Etxabe J,Vazquez JA.Morbidity and mortality in Cushing's disease:an epidemiological approach[J].Clin Endocrinol(Oxf),1994,40:479-484.
  • 9陈灏珠.实用内科学[M]北京:人民卫生出版社,20011077-1099.
  • 10廖二元;莫朝辉.内分泌学[M]北京:人民卫生出版社,20071298.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部